Navigation Links
Cardiovascular Diseases in India To be Studied Jointly By John Hopkins And Apollo Hospitals

Johns Hopkins Medicine International from the US and Apollo hospitals will undertake a combined study on the genetic reasons of cardiovascular disease in Indians.//

It was explained that in July last year, Apollo Hospitals had come into an agreement with Johns Hopkins to work jointly in areas like telemedicine, second opinion services, continuing medical education programmes, and participation in clinical trials.

Susan J. Zieman, assistant professor, medicines of John Hopkins on Tuesday in N.Delhi said, “The collaborative study will document the risk factors and identify genes that are associated with the premature CVD among Indians.” She further explained that the study is primarily being undertaken at the 3 Apollo hospitals, in Delhi, Hyderabad, and Chennai, to identify the risk factors in Asian Indians who have experienced myocardial infraction at a young age.

She further mentioning that “It will also investigate potential genetic variants associated with early onset of myocardial infraction, elevated risk factors and sub clinical CVD,” she said that the study will take samples from patients, their siblings and general people. Sunil Modi, a senior consultant and interventional cardiologist of the Apollo hospitals, while speaking to the media said, “Indians are 3.8 times more prone to the disease than residents of Singapore, three times more than Fijians, 2.4 times more than people of Trinidad, 1.4 times higher than South Africans and 1.5 times higher than British.”

Stating that almost around 8% of Indian population are probably suffering from heart diseases, Dr Modi said, “The study will take a sample of 1,500 people and conduct over 400 tests before reaching any conclusion. While the base of the study will be India, John Hopkins will provide us the some of the know how and research methodology. Of the over 400 tests some of the tests will also be conducted in the US. The clinical trails credibility of Johns Hopkins will definitely make our effort more meaningful.”

S.K. Aggarwal, a senior consultant in internal medicine said that the study would also look into the effect of administering ‘Polypill’ for reduction of CVD in patients. It was explained that Polypill is actually a mixture of three scheduled drugs, namely Aspirin, Statin, and ECE Inhibitor. It was explained that these three drugs are known for their action in reducing blood clot, cholesterol, and blood pressure.

Zieman said, “The polypill can be an effective medicine to reduce CVD but for that we will study the effect of the drug in its entirety. If successful the medicine can be used as a cost effective way to control the coronary heart diseases”


'"/>




Related medicine news :

1. High iron levels may cause Cardiovascular Disease in women
2. Air Pollution said To Increase Risk of Cardiovascular Disease
3. Link Between Alcohol Consumption And Cardiovascular Disease
4. Beer Found To Be Effective In Fighting Cardiovascular Disease
5. New Guidelines Found To Benefit Cardiovascular Treatment
6. Women With A High-Risk Of Cardiovascular Disease Under treated
7. Obesity and Physical inactivity is associated with Diabetes and Diabetes-Related Cardiovascular Comorbidities
8. Fitness levels in Men Correale with risk of Cardiovascular disease
9. Obesity Common Thread In Pregnancy Complications And Cardiovascular Woes
10. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
11. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... Texas (PRWEB) , ... May 26, 2016 , ... ... Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of community ... non-profit that restores, empowers, and renews hope for wounded service members and their families ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our ... PROTECTION TO YOUR HEAD ™”. , “We are proud to introduce Meghan ... football front we have Brian Quick, wide receiver for Los Angeles who was a ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: